AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,841,507 | +7.8% | 664,224 | +72.5% | 1.83% | +42.9% |
| Q2 2023 | $6,344,635 | +207.1% | 384,990 | -6.6% | 1.28% | +161.3% |
| Q3 2022 | $2,066,000 | +105.4% | 412,363 | 0.0% | 0.49% | +75.3% |
| Q2 2022 | $1,006,000 | -64.3% | 412,363 | 0.0% | 0.28% | -63.1% |
| Q1 2022 | $2,816,000 | -7.2% | 412,363 | +9.9% | 0.76% | +36.7% |
| Q4 2021 | $3,033,000 | -22.6% | 375,326 | -6.2% | 0.55% | -9.0% |
| Q3 2021 | $3,920,000 | – | 400,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |